IRIS Accounts Production v24.3.0.553 10722046 director 1.5.23 30.4.24 30.4.24 0 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh107220462023-04-30107220462024-04-30107220462023-05-012024-04-30107220462022-04-30107220462022-05-012023-04-30107220462023-04-3010722046ns15:EnglandWales2023-05-012024-04-3010722046ns14:PoundSterling2023-05-012024-04-3010722046ns10:Director12023-05-012024-04-3010722046ns10:PrivateLimitedCompanyLtd2023-05-012024-04-3010722046ns10:Micro-entities2023-05-012024-04-3010722046ns10:AuditExempt-NoAccountantsReport2023-05-012024-04-3010722046ns10:FullAccounts2023-05-012024-04-3010722046ns10:RegisteredOffice2023-05-012024-04-3010722046ns5:CurrentFinancialInstruments2024-04-3010722046ns5:CurrentFinancialInstruments2023-04-30
REGISTERED NUMBER: 10722046 (England and Wales)










Unaudited Financial Statements

for the Year Ended 30 April 2024

for

Cingulate Health Ltd

Cingulate Health Ltd (by shares) (Registered number: 10722046)

Contents of the Financial Statements
for the Year Ended 30 April 2024










Page

Company Information 1

Balance Sheet 2


Cingulate Health Ltd (by shares)

Company Information
for the Year Ended 30 April 2024







DIRECTOR: Dr S Das





REGISTERED OFFICE: Sharman Fielding House
57 New Walk
Leicester
Leicestershire
LE1 7EA





REGISTERED NUMBER: 10722046 (England and Wales)






Cingulate Health Ltd (by shares) (Registered number: 10722046)

Balance Sheet
30 April 2024

30.4.24 30.4.23
£    £    £    £   
Fixed assets 4,088 2,336

Current assets 36,824 35,193

Creditors
Amounts falling due within one year (40,788 ) (37,366 )
Net current liabilities (3,964 ) (2,173 )
Total assets less current liabilities 124 163

Capital and reserves 124 163

Note to the financial statements

1. Average number of employees

The average number of employees during the year was 1 (2023 - NIL ) .



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 2 December 2024 and were signed by:





Dr S Das - Director